Skip to main content

Table 1 Differential cell counts (percentages) in the bronchoalveolar lavage fluid after treatment with PBS or OVA inhalation and subcutaneous injection of 4T1 cells

From: Asthma-related inflammation promotes lung metastasis of breast cancer cells through CCL11–CCR3 pathway

Differential cell counts

n = 8

INH

INH + 4T1 subcutaneous injection

Cell type

PBS

OVA

PBS

OVA

Eosinophils

3.53 ± 0.39

29.5 ± 5.74

11 ± 1.86

17.3 ± 5.15

Neutrophils

6.1 ± 1.43

5.46 ± 1.39

27.35 ± 1.74

46.31 ± 5.16**

Lymphocytes

0.10 ± 0.10

0.0 ± 0.0

0.0 ± 0.0

0.77 ± 0.43

Epithelial cells

5.83 ± 1.93

5.13 ± 1.72

1.62 ± 0.69

2.81 ± 0.97

Macrophages

84.3 ± 2.8

59.7 ± 4.3*

59.9 ± 2.76

32.63 ± 6.6**

Proteins level expression of CCL11

n = 8

INH

INH + 4T1 subcutaneous injection

CCL11 (pg/ml)

PBS

OVA

PBS

OVA

Mean ± SEM

0,21 ± 0,04

0,58 ± 0,12*

0,36 ± 0,07

0,42 ± 0,08

  1. Proteins level expression of CCL11 (pg/ml) in lung of mice exposed to PBS or OVA and subcutaneously injected with 4T1 cells. *p < 0.05, **p < 0.01.